Evolve HESI Pharmacology Exam 2026 |
Newest Actual Study Guide with Actual Exam
Questions with Verified Answers (100%
Correct) and Rationales | Latest Update -
Graded A+
LATEST 2026 | 100% VERIFIED ANSWERS WITH RATIONALE | GRADED
A+ | 300 REAL EXAM-STYLE QUESTIONS | EVOLVE HESI
PHARMACOLOGY EXAM
Verified Questions, Answers and Rationales
300 Exam-Style Questions · Guaranteed Pass
Format: Q&A plus Rationales plus Why Grade: A+ / Guaranteed Pass
Wrong
Questions: 300 Exam-Style Questions Access: Instant PDF Download
100% verified correct answers with detailed Why Wrong sections for every incorrect option
pharmacology rationales
Covers all Evolve HESI Pharmacology topics: Includes cardiovascular, respiratory, endocrine,
pharmacokinetics, pharmacodynamics, drug neurologic, psychiatric, anti-infective, and
classes, adverse effects, nursing implications oncology agents
Addresses medication safety, dosage calculations, Based on the HESI Pharmacology Exam blueprint
drug interactions, and patient education and Evolve testing standards
High-yield content for nursing students and Instant PDF download – start studying
healthcare professionals immediately
Description
This Evolve HESI Pharmacology Exam 2026 study guide is designed to help you master the
essential pharmacology concepts needed to excel in your HESI Pharmacology Exam. Inside, you
,will find 300 practice questions that closely mirror the actual exam in style, difficulty, and content
distribution. We cover all key topics: pharmacokinetics and pharmacodynamics, cardiovascular
agents (antihypertensives, antiarrhythmics, anticoagulants, diuretics), respiratory agents
(bronchodilators, corticosteroids), endocrine agents (insulin, oral hypoglycemics, thyroid agents),
neurologic agents (anticonvulsants, anti-Parkinson drugs), psychiatric agents (antidepressants,
antipsychotics, anxiolytics), anti-infective agents (antibiotics, antivirals, antifungals), and oncology
agents. Each question comes with a 100% verified correct answer, a clear pharmacology rationale
that explains the reasoning behind it, and a targeted Why Wrong section that shows you exactly
why the other choices are incorrect. Updated for the latest testing cycle, this A+ graded review
will give you the confidence you need to pass your Evolve HESI Pharmacology Exam on the very
first attempt.
Abstract
This document provides a complete review of the Evolve HESI Pharmacology Exam through 300
realistic exam-style questions covering pharmacokinetics, pharmacodynamics, drug classes,
adverse effects, and nursing implications. Each question is paired with a 100% verified correct
answer, a detailed pharmacology rationale, and a thorough Why Wrong breakdown. Updated for
the latest testing cycle, this study guide is designed to help nursing students achieve a high score
and pass the Evolve HESI Pharmacology Exam with guaranteed accuracy.
Content Area Questions Key Topics Weight
Pharmacokinetics & 1 – 40 Absorption, distribution, metabolism, 13%
Pharmacodynamics excretion, receptor theory, dose-response,
therapeutic index.
Cardiovascular & Respiratory 41 – 90 Antihypertensives, diuretics, anticoagulants, 17%
Agents antiarrhythmics, bronchodilators,
corticosteroids.
Endocrine & Neurological 91 – 140 Insulin, oral hypoglycemics, thyroid agents, 17%
Agents anticonvulsants, antipsychotics,
antidepressants.
Anti-infective & 141 – 190 Antibiotics, antivirals, antifungals, vaccines, 17%
Immunologic Agents monoclonal antibodies, immunomodulators.
Psychiatric & Pain 191 – 240 Antidepressants, antipsychotics, anxiolytics, 17%
Management Agents opioids, NSAIDs, adjuvant pain medications.
,Content Area Questions Key Topics Weight
Medication Safety, Dosage 241 – 300 Safe administration, dosage calculations, drug 19%
& Nursing Implications interactions, adverse effects, patient
education, monitoring.
Pass your Evolve HESI Pharmacology Exam on your first attempt with this
comprehensive, A+ graded review.
300 Exam-Style Questions with Verified Answers
and Rationales
Qn 1. A patient with heart failure is prescribed digoxin. Which electrolyte imbalance
increases the risk of digoxin toxicity?
A A. Hyperkalemia
B B. Hypokalemia
C C. Hypernatremia
D D. Hyponatremia
Correct Answer: B. Hypokalemia
Rationale: Hypokalemia increases the risk of digoxin toxicity by increasing the binding of
digoxin to sodium-potassium ATPase. Low potassium levels should be corrected to prevent
toxicity.
Why Wrong:
A. A: Hyperkalemia decreases the risk of digoxin toxicity.
B. C: Hypernatremia does not directly affect digoxin toxicity.
C. D: Hyponatremia does not directly affect digoxin toxicity.
References: Evolve HESI Pharmacology Blueprint; Lehne's Pharmacology; Mosby's
Pharmacology Memory Notes; Saunders Comprehensive Review.
, Qn 2. A patient is prescribed fluconazole for a fungal infection. Which drug interaction
is significant?
A A. Warfarin
B B. Digoxin
C C. Metformin
D D. Lisinopril
Correct Answer: A. Warfarin
Rationale: Fluconazole inhibits CYP2C9 and can increase the anticoagulant effect of
warfarin, increasing the risk of bleeding. INR should be monitored.
Why Wrong:
A. B: Digoxin does not have a significant interaction with fluconazole.
B. C: Metformin does not have a significant interaction.
C. D: Lisinopril does not have a significant interaction.
References: Evolve HESI Pharmacology Blueprint; Lehne's Pharmacology; Mosby's
Pharmacology Memory Notes; Saunders Comprehensive Review.
Qn 3. A patient is prescribed albuterol for asthma. The nurse should monitor for which
common side effect?
A A. Bradycardia
B B. Tachycardia and nervousness
C C. Sedation
D D. Hyperkalemia
Correct Answer: B. Tachycardia and nervousness
Rationale: Albuterol is a beta-agonist bronchodilator that can cause tachycardia,
nervousness, and tremors due to beta-1 stimulation. These are common side effects.
Why Wrong:
A. A: Albuterol causes tachycardia, not bradycardia.
B. C: Albuterol causes stimulation, not sedation.
C. D: Albuterol can cause hypokalemia, not hyperkalemia.
References: Evolve HESI Pharmacology Blueprint; Lehne's Pharmacology; Mosby's
Pharmacology Memory Notes; Saunders Comprehensive Review.